SCNI

#5247
Scinai Immunotherapeutics Ltd - American Depositary Shares
0.0 0 USD
+2.27%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.00
0.00
Range Annuel
0.00
1.05
Changement quotidien
+2.27%
Changement Mensuel
-99.36%
Evolution sur 6 mois
-99.40%
Changement Annuel
-99.40%
Clôture Précédente
0.0 0
Open
0.0 0
Low
0.0 0
High
0.0 0
Volume
3
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 15.61 K
  • Employee 45
  • Founded 2003
  • CEO N/A
  • Website www.scinai.com
  • Headquarter Israel
  • FIGI BBG007TGL1R2
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
791.22
ratio cours/chiffre d'affaires
5 072.94

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

Nouvelles